Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients
- PMID: 34355291
- PMCID: PMC8342036
- DOI: 10.1007/s00784-021-04106-0
Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients
Abstract
Objectives: To evaluate the association and risk factors of healthcare-associated infection (HAI) and burden of illness among chemotherapy-induced ulcerative mucositis (UM) patients.
Methods: For this research, US National Inpatient Sample database 2017 was utilized to study UM patients. The association of healthcare-associated infection-related burden of illness among UM patients was assessed on the outcome--length of hospital stays (LOS), total charges, in-hospital mortality, and discharge disposition.
Result: In 2017, there were 11,350 adult (> 18 years of age) UM patients, among them there were 415 (3.5%) HAI. After adjusting for patient and clinical characteristics, UM patients with HAI were most likely to have higher total charges and longer LOS (1.91; 95% CIs: 1.51-2.41; P < 0.001; 1.84; 95% CIs: 1.53-2.21; P < 0.001) than those without HAI. Further, mortality was not significantly different. UM patients with HAI were less likely to have higher burden of illness who were younger, females, those living in non-metropolitan or micropolitan counties, and those with lower co-morbidity score. Additionally, UM patients with HAI were more likely to discharge to skilled nursing facility (SNF), intermediate care facility (ICF), and another type of facility (ATF), (aOR = 2.58 (1.16-5.76), P = 0.02), than they were to discharge to self-care or home care.
Conclusion: UM patients with HAI were more likely to have higher burden of illness and more likely to discharged to the SNF, ICF, and ATF rather than to home or self-care. Clinical relevance UM patients when associated with HAI have higher burden of illness; a tailored approach to oral care might prevent HAIs and burden of illness among UM.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients.Support Care Cancer. 2024 Dec 12;33(1):22. doi: 10.1007/s00520-024-09071-4. Support Care Cancer. 2024. PMID: 39666090
-
Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness.Pharmaceuticals (Basel). 2025 Apr 6;18(4):536. doi: 10.3390/ph18040536. Pharmaceuticals (Basel). 2025. PMID: 40283971 Free PMC article.
-
Association between palliative care referral and burden of illness among cancers of the lip, oral cavity and pharynx.Support Care Cancer. 2021 Dec;29(12):7737-7745. doi: 10.1007/s00520-021-06370-y. Epub 2021 Jun 22. Support Care Cancer. 2021. PMID: 34159429
-
Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma.Support Care Cancer. 2023 Mar 4;31(3):199. doi: 10.1007/s00520-023-07654-1. Support Care Cancer. 2023. PMID: 36869162
-
Controlling Costs and Changing Patient Care? The Role of Utilization Management.Washington (DC): National Academies Press (US); 1989. Washington (DC): National Academies Press (US); 1989. PMID: 25144100 Free Books & Documents. Review.
Cited by
-
Guided supportive care may benefit from predicting cancer treatment-induced toxicity-a methodology paper on utilization of nomograms to predict severe oral mucositis, Part I.Support Care Cancer. 2025 Jul 1;33(7):651. doi: 10.1007/s00520-025-09691-4. Support Care Cancer. 2025. PMID: 40593184 Free PMC article.
-
Cancer treatment-induced ulcerative mucositis serves as a significant predictor of burden of illness including dysphagia, and associated disparities among hospitalized cancer patients.Support Care Cancer. 2024 Dec 12;33(1):22. doi: 10.1007/s00520-024-09071-4. Support Care Cancer. 2024. PMID: 39666090
-
Hospitalized Cancer Patients with Opioid Management for Chemo-Induced Ulcerative Mucositis Lessens the Patients' Overall Burden of Illness.Pharmaceuticals (Basel). 2025 Apr 6;18(4):536. doi: 10.3390/ph18040536. Pharmaceuticals (Basel). 2025. PMID: 40283971 Free PMC article.
References
-
- Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, et al. Burden of Illness Head and Neck Writing Committee. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113(10):2704–13. doi: 10.1002/cncr.23898. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources